These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 34659554)

  • 1. Decreased interferon regulatory factor 6 expression due to DNA hypermethylation predicts an unfavorable prognosis in clear cell renal cell carcinoma.
    Li Z; Yang W; Qiu J; Xu H; Fan B; Li K; Zhou J; Li Y
    J Cancer; 2021; 12(22):6640-6655. PubMed ID: 34659554
    [No Abstract]   [Full Text] [Related]  

  • 2. [Correlation between methylation of interferon regulatory factor 6 gene promoter in renal tissues and overall survival of patients with Kidney renal clear cell carcinoma].
    Zhang J; Chen C; Wei Y; Chen L; Shao P; Xu H
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2024 Feb; 41(2):150-156. PubMed ID: 38311552
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Downregulation of Prognosis- and Immune Infiltration-Related Gene CYFIP2 Serves as a Novel Target in ccRCC.
    Tong J; Meng X; Lv Q; Yuan H; Li W; Xiao W; Zhang X
    Int J Gen Med; 2021; 14():6587-6599. PubMed ID: 34703279
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ACE2 Correlated With Immune Infiltration Serves As A Novel Prognostic Biomarker In Clear Cell Renal Cell Carcinoma: Implication For COVID-19.
    Yang W; Li L; Zhang K; Ma K; Xie H; Gong Y; Zhou J; Gong K
    Int J Biol Sci; 2021; 17(1):20-31. PubMed ID: 33390830
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition of KIF20A by transcription factor IRF6 affects the progression of renal clear cell carcinoma.
    Ma X; Wang X; Dong Q; Pang H; Xu J; Shen J; Zhu J
    Cancer Cell Int; 2021 May; 21(1):246. PubMed ID: 33941190
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CLDN10 associated with immune infiltration is a novel prognostic biomarker for clear cell renal cell carcinoma.
    Yang W; Li L; Zhang K; Ma K; Gong Y; Zhou J; Gong K
    Epigenomics; 2021 Jan; 13(1):31-45. PubMed ID: 33203244
    [No Abstract]   [Full Text] [Related]  

  • 7. Hypermethylation of the 16q23.1 tumor suppressor gene ADAMTS18 in clear cell renal cell carcinoma.
    Xu B; Zhang L; Luo C; Qi Y; Cui Y; Ying JM; Zhang Q; Jin J
    Int J Mol Sci; 2015 Jan; 16(1):1051-65. PubMed ID: 25569086
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Decreased expression of RASSF1A tumor suppressor gene is associated with worse prognosis in clear cell renal cell carcinoma.
    Klacz J; Wierzbicki PM; Wronska A; Rybarczyk A; Stanislawowski M; Slebioda T; Olejniczak A; Matuszewski M; Kmiec Z
    Int J Oncol; 2016 Jan; 48(1):55-66. PubMed ID: 26648328
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Immune-Related Gene HCST as a Novel Biomarker for the Diagnosis and Prognosis of Clear Cell Renal Cell Carcinoma.
    Zhou Y; Wang X; Zhang W; Liu H; Liu D; Chen P; Xu D; Liu J; Li Y; Zeng G; Li M; Wu Z; Zhang Y; Wang X; DiSanto ME; Zhang X
    Front Oncol; 2021; 11():630706. PubMed ID: 33968730
    [TBL] [Abstract][Full Text] [Related]  

  • 10. FAM72 family proteins as poor prognostic markers in clear cell renal carcinoma.
    Gou H; Chen P; Wu W
    Biochem Biophys Rep; 2023 Sep; 35():101506. PubMed ID: 37457361
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Low level of isocitrate dehydrogenase 1 predicts unfavorable postoperative outcomes in patients with clear cell renal cell carcinoma.
    Laba P; Wang J; Zhang J
    BMC Cancer; 2018 Aug; 18(1):852. PubMed ID: 30153799
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Study of Clinical Predictive Value and Immune Characterization of SLFN11 in Clear Cell Renal Cell Carcinoma.
    Liu Y; Zhang Z; Fu S; Wang S; Cheng X; Lei K; Li Z; Sun T; Ma M
    Int J Gen Med; 2021; 14():6741-6754. PubMed ID: 34675634
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Upregulation of ARNTL2 is associated with poor survival and immune infiltration in clear cell renal cell carcinoma.
    Wang S; Ma X; Ying Y; Sun J; Yang Z; Li J; Jin K; Wang X; Xie B; Zheng X; Liu B; Xie L
    Cancer Cell Int; 2021 Jul; 21(1):341. PubMed ID: 34217271
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Overexpression of FZD1 is Associated with a Good Prognosis and Resistance of Sunitinib in Clear Cell Renal Cell Carcinoma.
    Peng Q; Wang L; Zhao D; Lv Y; Wang H; Chen G; Wang J; Xu W
    J Cancer; 2019; 10(5):1237-1251. PubMed ID: 30854133
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Decreased expression of METTL14 predicts poor prognosis and construction of a prognostic signature for clear cell renal cell carcinoma.
    Wang Y; Cong R; Liu S; Zhu B; Wang X; Xing Q
    Cancer Cell Int; 2021 Jan; 21(1):46. PubMed ID: 33430867
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High expression levels of DEF6 predicts a poor prognosis for patients with clear cell renal cell carcinoma.
    Zhu ZP; Lin LR; Lv TD; Xu CR; Cai TY; Lin J
    Oncol Rep; 2020 Nov; 44(5):2056-2066. PubMed ID: 33000227
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification and validation of the clinical roles of the VHL-related LncRNAs in clear cell renal cell carcinoma.
    Yang W; Zhou J; Zhang K; Li L; Xu Y; Ma K; Xie H; Cai L; Gong Y; Gong K
    J Cancer; 2021; 12(9):2702-2714. PubMed ID: 33854630
    [TBL] [Abstract][Full Text] [Related]  

  • 18. DKC1 serves as a potential prognostic biomarker for human clear cell renal cell carcinoma and promotes its proliferation, migration and invasion via the NF‑κB pathway.
    Zhang M; Pan Y; Jiang R; Hou P; Shan H; Chen F; Jiang T; Bai J; Zheng J
    Oncol Rep; 2018 Aug; 40(2):968-978. PubMed ID: 29901172
    [TBL] [Abstract][Full Text] [Related]  

  • 19. TRIM2 downregulation in clear cell renal cell carcinoma affects cell proliferation, migration, and invasion and predicts poor patients' survival.
    Xiao W; Wang X; Wang T; Xing J
    Cancer Manag Res; 2018; 10():5951-5964. PubMed ID: 30538545
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A four-gene signature predicts survival in clear-cell renal-cell carcinoma.
    Dai J; Lu Y; Wang J; Yang L; Han Y; Wang Y; Yan D; Ruan Q; Wang S
    Oncotarget; 2016 Dec; 7(50):82712-82726. PubMed ID: 27779101
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.